Search
Design Therapeutics Inc
DSGNAdd to Watchlist
15.640USD
+0.980+6.68%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
976.58MMarket Cap
LossP/E TTM
Design Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-07-02The current valuation score of Design Therapeutics Inc is 6.81, ranking 292 out of 387 in the Biotechnology & Medical Research industry. Its current P/E ratio is -13.12, which is -88.28% below the recent high of -1.54 and -0.96% above the recent low of -13.24.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.